Accessibility Menu
Biotech Growth Trust Plc logo

Biotech Growth Trust Plc(LSE) BIOG

Market Cap£317.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)+1,443%
5 Year+33%
1 Year+104%
1 Month+7%
£16.80
+1.21%
+0.20Today
Biotech Growth Trust Plc last closing stock price
MetricPriceDate
Last closeGBX 1,692.002026-08-06
Biotech Growth Trust Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.8%GBX 1,630.002026-07-30
1 month+6.82%GBX 1,584.002026-07-07
3 month+27.79%GBX 1,324.002026-05-08
Year to date+41%GBX 1,200.002025-12-31
1 year+104.35%GBX 828.002025-08-06
3 year+118.6%GBX 774.002023-08-07
5 year+33.44%GBX 1,268.002021-08-06
Since inception+1,443.46%GBX 1.081997-06-23

Biotech Growth Trust Plc Financials at a Glance

Market Cap

£317.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£59.04M

Net Income (TTM)

£47.59M

EPS (TTM)

£5.58

P/E Ratio

2.97

Dividend

£0.00

Beta (Volatility)

0.03 (Low)

Price

£16.80

Volume

78,209

Open

£16.50

Previous Close

£16.80

Daily Range

£16.50 - £17.04

52-Week Range

£8.09 - £17.04

Estimated Earnings Date

Nov 25, 2025

BIOG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biotech Growth Trust Plc

The Biotech Growth Trust PLC is a closed-ended equity investment vehicle focused on the biotechnology sector. Managed by OrbiMed Capital LLC, the trust aims to invest in a diverse range of biotechnology companies across global public equity markets.

Products and Services
  • Investment in biotechnology companies across various market capitalizations
  • Portfolio construction based on rigorous fundamental analysis
  • Performance benchmarking against the NASDAQ Biotechnology Index
Growth Outlook
  • Recent quarterly revenue reached £63.8 million, showcasing strong market demand
  • Trailing twelve months (TTM) net income stands at £88.3 million, indicating robust profitability
  • Low P/E ratio of 2.86 suggests potential for future growth compared to industry peers
Financial Highlights
  • Market capitalization of approximately £304.6 million reflects solid investor interest
  • Net profit margin of 96.47% demonstrates exceptional operational efficiency
  • Cash flow from operations remains negative, indicating a need for strategic financial management
The Biotech Growth Trust PLC presents a compelling opportunity for investors interested in the biotechnology sector. With a focus on rigorous analysis and a diverse investment portfolio, the trust aims to capitalize on the growth potential of biotechnology companies. Recent financial performance highlights, including significant revenue and net income figures, underscore the trust's operational strength. However, the negative cash flow from operations may warrant attention as the company navigates its financial strategy. Overall, the Biotech Growth Trust PLC stands as a noteworthy player in the biotechnology investment landscape.
AI Generated • Jul 19, 2026

Industry

Capital Markets

Sector

Financials

Employees

0

Website

biotechgt.com

Headquarters

London, NY EC2V 7WS, GB

BIOG Financials

Key Financial Metrics (TTM)

Gross Margin

98.21%

Operating Margin

97.68%

Net Income Margin

96.47%

Return on Equity

48.26%

Return on Capital

44.82%

Return on Assets

43.10%

Earnings Yield

33.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£317.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

19.11M

Volume

78.21K

Avg. Volume

58.21K

Financials (TTM)

Gross Profit

£55.40M

Operating Income

£52.25M

EBITDA

£51.71M

Operating Cash Flow

-£11.66M

Capital Expenditure

£0.00

Free Cash Flow

-£11.66M

Cash & ST Invst.

£0.00

Total Debt

£12.32M

Biotech Growth Trust Plc Performance Analysis

Biotech Growth Trust Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP -30,635,000-85.1%
20242024-03-31GBP 81,872,000N/A
20252025-03-31GBP -73,922,000N/A
20262026-03-31GBP 137,156,000N/A
Biotech Growth Trust Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-88.6%
Q42025-03-31-931.3%
Q22025-09-30182.4%
Q42026-03-31-10.4%
Biotech Growth Trust Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP -1.03-79.0%
20242024-03-31GBP 2.07N/A
20252025-03-31GBP -2.62N/A
20262026-03-31GBP 5.58N/A
Biotech Growth Trust Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-89.8%
Q42025-03-31-1248.0%
Q22025-09-30195.1%
Q42026-03-314.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£63.82M

-29.7%

Gross Profit

£62.50M

-28.6%

Gross Margin

97.93%

N/A

Market Cap

£317.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

£60.83M

-31.1%

EBITDA

£61.66M

-30.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£0.00

-100.0%

Total Debt

£12.32M

-73.8%

Accounts Receivable

£11.00M

-24.2%

Inventory

£0.00

N/A

Long Term Debt

£0.00

N/A

Short Term Debt

£12.32M

-73.8%

Return on Assets

43.10%

N/A

Return on Invested Capital

45.49%

N/A

Free Cash Flow

-£3.46M

-46.0%

Operating Cash Flow

-£3.46M

-46.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IBT.LInternational Biotechnology Trust plc
£10.75+2.38%
DIVI.LThe Diverse Income Trust plc
£1.18+1.29%
BGUK.LBaillie Gifford UK Growth Trust plc
£2.27+0.89%
AJOT.LAVI Japan Opportunity Trust PLC
£1.68+0.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$114.92+0.06%
NVDANvidia
$218.99-0.00%
TTDThe Trade Desk
$17.67-0.07%
SOUNSoundHound AI
$7.08+0.10%

Questions About BIOG

What is the current price of Biotech Growth Trust Plc?

Biotech Growth Trust Plc is trading at £16.80 per share.

What is the 52-week range for Biotech Growth Trust Plc?

Over the past 52 weeks, Biotech Growth Trust Plc has traded between £8.09 and £17.04.

How much debt does Biotech Growth Trust Plc have?

As of the most recent reporting period, Biotech Growth Trust Plc reported total debt of £12.32M.

How much cash does Biotech Growth Trust Plc have on hand?

Biotech Growth Trust Plc reported £0.00 in cash and cash equivalents in its most recent financial results.

What is Biotech Growth Trust Plc’s dividend yield?

Biotech Growth Trust Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services